Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2017–2022 · research · R01
Fasting Protects Small Intestinal Stem Cells from Lethal DNA Damage: Mechanistic Insight and Preclinical Translation
Helen M Piwnica-Worms · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
The roles of TRIM24 in breast cancer
Guillermina Lozano · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2024 · research · R01
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017 · grant · Academic Research
Targeting ubiquitination for cancer therapy
Shuxing Zhang · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2017–2023 · research · R01
Define redundant functions of H2AX and NBS1 in DNA repair
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2021 · award
Characterizing the epigenetic consequences of ATRX deficiency in cancer
Jason Huse · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2017–2023 · cooperative agreement · U01
Integrating Biospecimen Science Into The Development Of RNA-Based Clinical Assays For Patients With Metastatic Breast Cancer
William F Symmans · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2024 · research · R01
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Rational Combination Therapy with PARP Inhibitors in Triple Negative Breast Cancer
Liuqing Yang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017 · award
Cooperative mechanisms of pancreatic cancer metastasis
Michael Kim · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2017–2022 · research · R01
Enhancing anti-EGFR Therapeutic Efficacy in Inflammatory Breast Cancer
Naoto T. Ueno · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2019 · research · R03
Improving dose coverage of tumor periphery in radiotherapy of lung cancer through the use of flattening filter free beams
Oleg Vassiliev · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · career development · K08
Defining diverse roles of p53 in pancreatic cancer
Michael Paul Kim · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · research · R01
The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma
Paul J Chiao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma
Paul J Chiao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2020 · cooperative agreement · U24
Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Significance of Inhibiting Long Non-coding RNAs in Advanced Breast Cancer
Chunru Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches
Sunil Krishnan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · research · R01
53BP1-dependent pathway in DNA repair
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Define redundant functions of H2AX and NBS1 in DNA repair
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2019 · contract · N01
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oopherectomy
Powel Brown · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2021 · research · R01
Define redundant functions of H2AX and NBS1 in DNA repair
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · career development · K08
Defining diverse roles of p53 in pancreatic cancer
Michael Paul Kim · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2021 · program · P20
2/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
Lorna H. Mcneill · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2019 · research · R21
Using hunger training to enhance weight loss and modulate cancer-related biomarkers in women at high risk for breast cancer: a pilot study
Susan Schembre · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2024 · research · R35
Harnessing the power of exosomes for non-coding RNA delivery
Anil K Sood · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R25
Scientific Communication Advances Research Excellence (SCOARE)
Carrie A. Cameron · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · program · P01
Processing and Repair of DNA Crosslinks
Richard D Wood · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Combinatorial Treatment Strategies to Counteract EGFR Resistance
Liuqing Yang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2020 · research · R00
The SMYD3-ERK5 signaling module in pancreatic cancer
Pawel K. Mazur · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2020 · research · R21
Understanding Uncertainties in Radiomics Studies
Laurence E Court · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Rational Combination Therapy with PARP Inhibitors in Triple Negative Breast Cancer
Mien-Chie Hung · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
The roles of TRIM24 in breast cancer
Michelle Ann Barton · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Preclinical characterization of EMT/CSC-specific small molecule inhibitors for TNBCs
Luke Lee Lairson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2020 · fellowship · F31
Elucidating the Role of Fasting in GI Radioprotection: Applications in Pre-Clinical Pancreatic Cancer Model
Marimar De La Cruz Bonilla · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2020 · research · R21
Palliative Therapies for Refractory Delirium in Advanced Cancer
David Hui · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2028 · cooperative agreement · U24
MD Anderson Cancer Immune Monitoring and Analysis Center MDA-CIMAC
Gheath Al-Atrash · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2027 · research · R25
Scientific Communication Advances Research Excellence (SCOARE) 2.0
Carrie A. Cameron · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · research · R01
MSC-Derived Exosomes and MicroRNA in Glioma Therapy
Frederick F Lang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Integrating Biospecimen Science Into The Development Of RNA-Based Clinical Assays For Patients With Metastatic Breast Cancer
William F Symmans · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
